Japanese trial enrollment is so quick. A phase II trial of CS-3150 needs to recruit 400 patients, started on January19, and finished enrollment at May7, expecting Primary Completion Date to be December. Why seriously did it take so long to start?
They had all their forms ready before the cut-off date. Only to fill the blanks after the data. That's why it took them less than 20 days to submit NDA after PR. What was MMM doing? Trimming hair.
75 slots（=7500 shrs) or 75 shares? If only 75 shares, congratulations! You made a killing with $200 and something. It's extremely hard considering transaction fee.
Who has all the NK, CAR-T, Check point, targeted chemical candidates? And how much does it cost for you to buy them all? 1/15! comparing to FBIO, NK is expensive.
2015_05_27's change, you can see how many deletions are there. Don't forget to uncheck "Hide non-essential portions"
It's like an XML files compare.
If you check the update status of celestial, you may find something interesting. After 2014_10_27, they suddenly stopped updating for half year. That was normal behavior like before then. And then finally came out saying that clinical trial sites amount was cut. It sounds like they slow down enrollment after the big layoff.
cabo is directly compete with sunitinib, especially after cabosun and celestial. And buying out cabo won't give it any synergy. Sutent's more than one billion market will erode fast next year.
Will the number 259 be adjusted according to drop out rate, or be fixed at that? If 259 is rigid, this number will take long time to reach with a 15% drop out rate.
Kinda agree. Some patients on some forum express the same idea. cabo works, but with strong se. It needs better result to take over other TKI's market. Don't know if the dropout has effect on meteor cut-off date.